P Plenary opening session: Rising to the challenge - Reducing the global burden of disease
Monday 29 August 2016
Hilton Buenos Aires : Pacifico A & B, 3 hours
Organised by the FIP Programme Committee
Simultaneous translation in Spanish
Our role in improving the outcomes of treatments is the essence of the pharmacy profession and of the pharmaceutical sciences. Creating, preparing and providing medicines are based on this role.
Moving from a sickness model to a health model means that pharmacy is now also about disease prevention and health promotion.
Pharmaceutical scientists, pharmacists and pharmacy educators are dedicated to integrating evidence-based practice to improve the use of medicines. Innovation that creates new treatment options with medicines, collaborative practices (not only within health professionals, but also individuals and communities themselves), practices that improve the use of medicines, prevention (of both diseases and complications from existing disease) and public health programmes all have the potential to reduce the global burden of disease.
In addition, interprofessional education must meet higher quality criteria in order to increase impact and create new context for health care professionals.
The professional symposia at this congress will explore the many ways in which you can respond to global health needs through practice, science and education to reduce the burden of disease and improve quality of life.
At the conclusion of this knowledge-based session, participants will be able to:
- Describe the meaning of “global burden of disease”
- Describe the burden of disease on health care systems
- Identify the various factors that influence government health care budgets
- Outline the role of pharmacy in reducing the burden of disease
- Outline educational strategies for pharmacists for these roles.
Betty Chaar (University of Sydney, Australia) and Dominique Jordan (pharmasuisse, Switzerland)
1) Setting the scene
2) a) The global burden of disease — from the perspective of health literacy and the role of pharmacy
Don Nutbeam (University of Southampton, UK)
3) What is the role of pharmacy in reducing the global burden of disease?
Tana Wuliji (WHO, Switzerland)
10:30 -10:50 Coffee/tea break
4) How do we prepare pharmacists for these roles?
Henri Manasse (American Society of Health-System Pharmacists, USA)
5) Panel discussion